The metastasis-promoting roles of tumor-associated immune cells
Open accessThe DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Abstract
Tumor metastasis is driven not only by the accumulation of intrinsic alterations in malignant cells, but also by the interactions of cancer cells with various stromal cell components of the tumor microenvironment. In particular, inflammation and infiltration of the tumor tissue by host immune cells, such as tumor-associated macrophages, myeloid-derived suppressor cells, and regulatory T cells, have been shown to support tumor growth in addition to invasion and metastasis. Each step of tumor development, from initiation through metastatic spread, is promoted by communication between tumor and immune cells via the secretion of cytokines, growth factors, and proteases that remodel the tumor microenvironment. Invasion and metastasis require neovascularization, breakdown of the basement membrane, and remodeling of the extracellular matrix for tumor cell invasion and extravasation into the blood and lymphatic vessels. The subsequent dissemination of tumor cells to distant organ sites necessitates a treacherous journey through the vasculature, which is fostered by close association with platelets and macrophages. Additionally, the establishment of the pre-metastatic niche and specific metastasis organ tropism is fostered by neutrophils and bone marrow-derived hematopoietic immune progenitor cells and other inflammatory cytokines derived from tumor and immune cells, which alter the local environment of the tissue to promote adhesion of circulating tumor cells. This review focuses on the interactions between tumor cells and immune cells recruited to the tumor microenvironment and examines the factors allowing these cells to promote each stage of metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–226 of 226
Sevenich, L., Werner, F., Gajda, M., Schurigt, U., Sieber, C., Müller, S., Follo, M., Peters, C., & Reinheckel, T. (2011) · Oncogene · doi:10.1038/onc.2010.387 · Cited by 85
Neil, J. R., & Schiemann, W. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3094 · Cited by 83
Roles of Metalloproteases in Metastatic Niche
Rucci, N., Sanità, P., & Angelucci, A. (2011) · Current Molecular Medicine · doi:10.2174/156652411797536705 · Cited by 82
Natsuizaka, M., Ohashi, S., Wong, G. S., Ahmadi, A., Kalman, R. A., Budo, D., Klein–Szanto, A. J., Herlyn, M., Diehl, J. A., & Nakagawa, H. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq108 · Cited by 79
Inflammation linking EMT and cancer stem cells
Zhou, C., Liu, J., Tang, Y., & Liang, X. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.06.005 · Cited by 71
Interleukin-6 Increases Expression and Secretion of Cathepsin B by Breast Tumor-Associated Monocytes
Mohamed, M. M., Cavallo‐Medved, D., Rudy, D., Anbalagan, A., Moin, K., & Sloane, B. F. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000276564 · Cited by 69
B Lymphocytes Promote Lymphogenous Metastasis of Lymphoma and Melanoma
Ruddell, A., Harrell, M. I., Furuya, M. H., Kirschbaum, S. B., & Iritani, B. M. (2011) · Neoplasia · doi:10.1593/neo.11756 · Cited by 68
Chronic Inflammation and Immunologic-Based Constraints in Malignant Disease
Lowe, D. B., & Storkus, W. J. (2011) · Immunotherapy · doi:10.2217/imt.11.113 · Cited by 65
Myeloid cells in tumor inflammation
Schmid, M. C., & Varner, J. A. (2012) · Vascular Cell · doi:10.1186/2045-824x-4-14 · Cited by 65
Mast cell tryptase promotes breast cancer migration and invasion
Chen (2010) · Oncology Reports · doi:10.3892/or_00000676 · Cited by 62
Park, J. I., Lee, M. G., Cho, K. H., Park, B. J., Chae, K. S., Byun, D.-S., Ryu, B. K., Park, Y. K., & Chi, S.-G. (2004) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2003.12.015 · Cited by 60
Karnezis, T., Shayan, R., Fox, S. B., Achen, M. G., & Stacker, S. A. (2012) · Oncotarget · doi:10.18632/oncotarget.593 · Cited by 59
The pro‐metastatic role of bone marrow‐derived cells: a focus on MSCs and regulatory T cells
Koh, B. I., & Kang, Y. (2012) · EMBO Reports · doi:10.1038/embor.2012.41 · Cited by 55
Self-citationIida (2010) · Oncology Reports · doi:10.3892/or.2010.1118 · Cited by 54
Leukocytes as paracrine regulators of metastasis and determinants of organ‐specific colonization
Erez, N., & Coussens, L. M. (2011) · International Journal of Cancer · doi:10.1002/ijc.26032 · Cited by 50
Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes
Fordyce, C. A., Patten, K. T., Fessenden, T. B., DeFilippis, R., Hwang, E. S., Zhao, J., & Tlsty, T. D. (2012) · Breast Cancer Research · doi:10.1186/bcr3368 · Cited by 50
Novel Bone-Targeted Strategies in Oncology
Vallet, S., Smith, M. R., & Raje, N. S. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0600 · Cited by 46
Antimetastatic Effect of an Orally Active Heparin Derivative on Experimentally Induced Metastasis
Lee, D. Y., Park, K., Kim, S. K., Park, R., Kwon, I. C., Kim, S. Y., & Byun, Y. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0641 · Cited by 45
Mendoza, L., Valcárcel, M., Carrascal, T., Egilegor, E., Salado, C., Sim, B. K. L., & Vidal‐Vanaclocha, F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1829 · Cited by 44
Genomic Predictors of Outcome and Treatment Response in Breast Cancer
Dunn, L. A., & DeMichele, A. M. (2009) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256317 · Cited by 43
Metastatic Melanomas Express Inhibitory Low Affinity Fc Gamma Receptor and Escape Humoral Immunity
Cohen-Solal, J. F. G., Cassard, L., Fournier, E. M., Loncar, S. M., Fridman, W. H., & Sautès‐Fridman, C. (2010) · Dermatology Research and Practice · doi:10.1155/2010/657406 · Cited by 29
iNKT Cells Suppress the CD8+ T Cell Response to a Murine Burkitt’s-Like B Cell Lymphoma
Bjordahl, R., Gapin, L., Marrack, P., & Refaeli, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042635 · Cited by 28
Convergent pathways of macrophage polarization: The role of B cells
Sica, A., Porta, C., Riboldi, E., & Locati, M. (2010) · European Journal of Immunology · doi:10.1002/eji.201040736 · Cited by 26
Brown, K. S., Blair, D., Reid, S. D., Nicholson, E., & Harnett, M. M. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(03)00113-x · Cited by 23
Know thy enemy: Why are tumor-infiltrating regulatory T cells so deleterious?
Facciabene, A., Santoro, S. P., & Coukos, G. (2012) · OncoImmunology · doi:10.4161/onci.19401 · Cited by 18
uPA and uPA-receptor are involved in cancer-associated myeloid-derived suppressor cell accumulation.
Ilkovitch, D., Carrió, R., & Lopez, D. M. (2012) · PubMed · Cited by 16
Cited by
Molecular principles of metastasis: a hallmark of cancer revisited
Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A., & Fares, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0134-x · Cited by 2,379
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Alix-Panabières, C., & Pantel, K. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1483 · Cited by 1,394
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Marvel, D., & Gabrilovich, D. I. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80005 · Cited by 1,050
Three-dimensional culture systems in cancer research: Focus on tumor spheroid model
Nath, S., & Devi, G. R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.013 · Cited by 919
Metadata
- Authors
- Smith, H. A., & Kang, Y.
- Venue
- Journal of Molecular Medicine
- Published
- 2013-03-21
- Volume
- 91
- Issue
- 4
- Pages
- 411-429
- ISSN
- 0946-2716 (ISSN-L)
- 1432-1440
- OpenAlex
- W2030028321
- Cited by
- 367
- References
- 226
- FWCI
- 16.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.